EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 3.0

LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients

Na Yang, Xinxin Zheng, Xinyue Ji, Hui Yao, Ke Xu, Tianqi Zhang, Lu Jin, Huaijun Zhu, Min Wang

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s539874 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Na Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, P…. Hauptthemen laut MEDLINE: Tigecycline, Metabolomics, Anti-Bacterial Agents, Blood Coagulation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TigecyclineMetabolomicsAnti-Bacterial AgentsBlood Coagulation DisordersHumansCritical IllnessMaleFemaleMiddle AgedAgedChromatography, LiquidAdultLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

coagulopathycritically ill patientsmetabolomicspredictiontigecycline

Substanzen

TigecyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China.
  • Department of Pharmacy, Hospital of Zhejiang People's Armed Police (PAP), Hangzhou, People's Republic of China.

Zitieren

APA

Yang, N., Zheng, X., Ji, X., Yao, H., Xu, K., Zhang, T., Jin, L., Zhu, H., & Wang, M. (2025). LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s539874

Vancouver

Yang N, Zheng X, Ji X, Yao H, Xu K, Zhang T, et al. LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s539874

BibTeX
@article{Yang2025,
  author = {Yang, Na and Zheng, Xinxin and Ji, Xinyue and Yao, Hui and Xu, Ke and Zhang, Tianqi and Jin, Lu and Zhu, Huaijun and Wang, Min},
  title = {LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s539874}
}
Kostenlos starten →